Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillat… https://t.co/6BkkmZ5Ywc
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @pharma_pon: CKDの人へのDOAC、コクランレビュー
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @pharma_pon: CKDの人へのDOAC、コクランレビュー
CKDの人へのDOAC、コクランレビュー
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
RT @ISNeducation: 7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- api…
7/ CKD and DOACs Cochrane review 12,545 patients with CKD (eGFR>30) across 5 clinical trials randomized to DOACs- apixaban, rivaroxaban, edoxaban, or dabigatran 🆚Warfarin DOACs show ☑️⬇️risk of stroke+systemic embolism; trend👉less major bleeding h
Según esta RS y Metaanálisis Cochrane los DOACs son tan eficaces como warfarina para prevenir #ECV y embolismos sistémicos en sujetos con #FA y #ERC estadios G3-G4; sin aumentar significativamente los sangrados mayores.#CKD #ICU #medtwitter 👉https://t.co/
DOAC are as likely as warfarin to prevent all strokes and systemic embolic events without increasing major bleeding events among AF patients with CKD. #CochraneEvidence https://t.co/r8HjSRLKDE
RT @jmparedero: ACOD y la warfarina pueden prevenir todos los accidentes cerebrovasculares y los eventos embólicos sistémicos sin aumentar…
RT @jmparedero: ACOD y la warfarina pueden prevenir todos los accidentes cerebrovasculares y los eventos embólicos sistémicos sin aumentar…
RT @jmparedero: ACOD y la warfarina pueden prevenir todos los accidentes cerebrovasculares y los eventos embólicos sistémicos sin aumentar…
ACOD y la warfarina pueden prevenir todos los accidentes cerebrovasculares y los eventos embólicos sistémicos sin aumentar los eventos hemorrágicos graves entre los pacientes con FA y ERC https://t.co/rifFanKEqo
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los ACOD vs warfarina en pac con FA y ERC https://t.co/dB4hitesGg
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los ACOD vs warfarina en pac con FA y ERC https://t.co/dB4hitesGg
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los ACOD vs warfarina en pac con FA y ERC https://t.co/dB4hitesGg
(Cochrane) Seguridad y eficacia de los ACOD vs warfarina en pac con FA y ERC https://t.co/dB4hitesGg
In patients with A fib and CKD (stage 3), DOACs reduce intracranial hemorrhage, but not overall stroke, systemic embolic events, or all-cause mortality, compared to warfarin. #DOAC #CKD #FOAMed https://t.co/sy7FJ7q1UX
RT @syuichiao89: CKD+AF患者におけるDOACとワルファリン比較 コクランSRhttps://t.co/XsvkkFDe9B
RT @syuichiao89: CKD+AF患者におけるDOACとワルファリン比較 コクランSRhttps://t.co/XsvkkFDe9B
RT @syuichiao89: CKD+AF患者におけるDOACとワルファリン比較 コクランSRhttps://t.co/XsvkkFDe9B
CKD+AF患者におけるDOACとワルファリン比較 コクランSRhttps://t.co/XsvkkFDe9B
RT @cochrane_russia: Новые пероральные антикоагулянты в сравнении с варфарином для профилактики инсульта и системной эмболии у пациентов с…
RT @Bibliosaude: Anticoagulantes orales directos para la prevención del accidente cerebrovascular en pacientes con fibrilación auricular y…
Anticoagulantes orales directos para la prevención del accidente cerebrovascular en pacientes con fibrilación auricular y nefropatía crónica. Revisión Cochrane https://t.co/Zmem4aaEMm
RT @Actual_clinica: Anticoagulantes orales directos versus warfarina para la prevención del accidente cerebrovascular y los eventos embólic…
Anticoagulantes orales directos versus warfarina para la prevención del accidente cerebrovascular y los eventos embólicos sistémicos en los pacientes con fibrilación auricular y nefropatía crónica Cochrane https://t.co/rnYj4st9Bb
RT @Actual_clinica: Anticoagulantes orales directos para la prevención del accidente cerebrovascular en pacientes con fibrilación auricular…
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney... - PubMed - NCBI https://t.co/6c0QpR79ok
Anticoagulantes orales directos para la prevención del accidente cerebrovascular en pacientes con fibrilación auricular y nefropatía crónica Cochrane https://t.co/cM4NQ5ha2U
RT @CochraneLibrary: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD ht…
Meta-analyse Cochrane => DOACs versus VKA for preventing stroke a and systemic embolic events among atrial fibrillation patients with chronic kidney disease https://t.co/cInWsvvsBX
RT @Vannyamoto: AF合併CKD患者におけるDOACとワルファリンの比較2017 SR&MA https://t.co/grkSYz8sNx
AF合併CKD患者におけるDOACとワルファリンの比較2017 SR&MA https://t.co/grkSYz8sNx
RT @CochraneUK: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD https:/…
RT @CochraneLibrary: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD ht…
RT @CochraneUK: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD https:/…
RT @CochraneUK: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD https:/…
RT @CochraneUK: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD https:/…
RT @CochraneUK: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD https:/…
It makes me happy that I know what's going on in papers like this now. #NonMedicalPrescribing #WhoDoesntLoveADOAC? #ThoseWithMechanicalHeartValves https://t.co/B5HjK7kZJ1
@CochraneLibrary Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease https://t.co/khRwGOGtIZ
RT @CochraneLibrary: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD ht…
RT @CochraneLibrary: #CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD ht…
#CochraneEvidence: #DOAC as likely as warfarin to prevent strokes & systemic embolic events in #AF patients w/ #CKD https://t.co/5pvHGw3MkO
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
Direct oral anticoagulants for prevention of stroke in atrial fibrillation patients with… https://t.co/UwBqGcuR0T
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic… https://t.co/BvQoOY7Ijw
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
RT @CochraneKidney: New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.…
New #CochraneReview: Direct oral anticoagulants vs warfarin for preventing stroke among AF patients with CKD https://t.co/ntilf264U4 https://t.co/XHm1hhEZCe
#Anticoagulants vs #Warfarin for preventing #stroke among atrial fibrillation patients with chronic #kidney disease: https://t.co/zl3XOXgI71 https://t.co/ZaJsvbpUDA
Cochrane DOAC = VKA in those with renal impairment https://t.co/hkk9MR7iPZ
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic… https://t.co/uKxQ4jtO5c